Research Article
Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients
Table 2
Multivariate analysis of the overall survival and disease-free survival in glioma patients.
| Variables | Overall survival | Disease free survival | HR | 95% CI | value | HR | 95% CI | value |
| Age | 0.882 | 0.452-1.342 | 0.233 | 1.113 | 0.673-1.732 | 0.143 | Gender | 1.442 | 0.642-2.104 | 0.342 | 1.632 | 0.773-2.341 | 0.219 | WHO grade | 2.893 | 1.324-4.872 | 0.009 | 3.014 | 1.432-5.118 | 0.005 | KPS score | 2.782 | 1.423-4.563 | 0.013 | 2.964 | 1.395-4.895 | 0.007 | Tumor size | 1.237 | 0.672-1.897 | 0.213 | 1.427 | 0.875-2.137 | 0.136 | ZNF667-AS1 expression | 2.897 | 1.365-4.784 | 0.008 | 3.019 | 1.414-4.899 | 0.005 |
|
|